Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Mar;115(3):774-9.
doi: 10.1172/JCI23625.

Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice

Affiliations

Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice

Jason E Kralic et al. J Clin Invest. 2005 Mar.

Abstract

Essential tremor is the most common movement disorder and has an unknown etiology. Here we report that gamma-aminobutyric acidA (GABA(A)) receptor alpha1-/- mice exhibit postural and kinetic tremor and motor incoordination that is characteristic of essential tremor disease. We tested mice with essential-like tremor using current drug therapies that alleviate symptoms in essential tremor patients (primidone, propranolol, and gabapentin) and several candidates hypothesized to reduce tremor, including ethanol; the noncompetitive N-methyl-D-aspartate receptor antagonist MK-801; the adenosine A1 receptor agonist 2-chloro-N6-cyclopentyladenosine (CCPA); the GABA(A) receptor modulators diazepam, allopregnanolone, and Ro15-4513; and the L-type Ca2+ channel antagonist nitrendipine. Primidone, propranolol, and gabapentin reduced the amplitude (power) of the pathologic tremor. Nonsedative doses of ethanol eliminated tremor in mice. Diazepam, allopregnanolone, Ro15-4513, and nitrendipine had no effect or enhanced tremor, whereas MK-801 and CCPA reduced tremor. To understand the etiology of tremor in these mice, we studied the electrophysiological properties of cerebellar Purkinje cells. Cerebellar Purkinje cells in GABA(A) receptor alpha1-/- mice exhibited a profound loss of all responses to synaptic or exogenous GABA, but no differences in abundance, gross morphology, or spontaneous synaptic activity were observed. This genetic animal model elucidates a mechanism of GABAergic dysfunction in the major motor pathway and potential targets for pharmacotherapy of essential tremor.

PubMed Disclaimer

Figures

Figure 1
Figure 1
GABAA receptor α1–/– mice exhibit essential-like tremor. Normal physiologic tremor (wide range of low-power frequencies, 25–40 Hz) was observed in α1+/+, α1+/–, and α1–/– mice. Knockout mice also exhibited pathologic tremor (small range of high-power frequencies, 17–21 Hz) characteristic of essential tremor. Representative voltage tracings and Fourier transformation of tremor-induced displacement is shown for α1+/+ (A), α1+/– (B), and α1–/– (C) mice. (A) α1+/+ mice exhibit a tremor with a mean maximal power of 2.6 × 1011 ± 3.2 × 1011 N and a mean frequency of 32.1 ± 0.6 Hz (n = 16); (B) α1+/– mice, mean maximal power of 6.0 × 1011 ± 1.1 × 1011 N and mean frequency of 35.0 ± 1.9 Hz (n = 5); (C) α1–/– mice, mean maximal power of 24.3 × 1011 ± 4.2 × 1011 N and mean frequency of 19.3 ± 0.9 Hz (n = 13). Tremor is plotted as the voltage generated upon displacement of the transducer as a function of time (seconds). The power of individual frequencies that contribute to the overall tremor was determined by Fourier transformation of the voltage trace over time.
Figure 2
Figure 2
Inhibition of essential-like tremor in GABAA receptor α1–/– mice by ethanol and MK-801. (A) Ethanol (0.25–2.5 g/kg) inhibited the essential-like tremor (approximately 19 Hz) in α1–/– mice in a dose-dependent manner with an ED50 of 0.35 mg/kg reaching a maximal inhibition of 100% (n = 5–11 per genotype). Ethanol (0.25 g/kg) increased physiological tremor (approximately 32 Hz) in α1+/+ mice but lacked any effect at higher doses. (B) MK-801 (0.01–0.2 mg/kg) reduced the approximately 19 Hz tremor power in α1–/– mice with an ED50 of 0.024 mg/kg reaching a maximal inhibition of 65–80% (n = 5–6). *P < 0.05; **P < 0.01; ***P < 0.001.
Figure 3
Figure 3
GABAA receptor α1–/– mice exhibit normal Purkinje cell number and morphology but complete loss of both spontaneous mIPSCs and exogenous GABA inhibition of whole-cell voltage-clamp electrophysiological responses. (A) Calbindin staining of Purkinje cell number and morphology in cerebellum of 8-month-old α1+/+ and α1–/– mice. Magnification, ×400. (B) Similar spontaneously active Purkinje cells were found in both α1+/+ (22 of 29 penetrations) and α1–/– (28 of 36 penetrations) mice. Mean rate for α1–/– mice (26.7 ± 3.8) did not differ from that of α1+/+ mice (32.4 ± 5.5). (C) Spontaneous mIPSCs recorded over a 30-second period from a Purkinje cell mechanically dissociated from an α1+/+ and α1–/– mouse. Spontaneous postsynaptic picrotoxin-sensitive currents with amplitude greater than 50 pA and fall-times greater than 4 ms were recorded from 10 of 16 α1+/+ mice and 0 of 14 α1–/– mice. (D) Whole-cell voltage-clamp recordings were obtained from mechanically dissociated cerebellar Purkinje cells from α1+/+ and α1–/– mice. GABA was applied to the neurons by a U-tube. GABA (3, 30, and 100 μM) gated a concentration-dependent inward current when applied to Purkinje cells from α1+/+ mice, but no current was gated in α1–/– Purkinje cells. (E) Mean GABA-gated currents from cerebellar Purkinje cells mechanically isolated from α1+/+ or α1–/– mice. There was a statistically reliable concentration-related increase in GABA response in the α1+/+ mice (*P < 0.001) but no effect of GABA in the α1–/– mice (P > 0.1) (n = 6–11 neurons per group).

Comment in

Similar articles

Cited by

References

    1. Louis ED, Ottman R, Hauser WA. How common is the most common adult movement disorder? Estimates of the prevalence of essential tremor throughout the world. Mov. Disord. 1998;13:5–10. - PubMed
    1. Chen JJ, Swope DM. Essential tremor: diagnosis and treatment. Pharmacotherapy. 2003;23:1105–1122. - PubMed
    1. Pahwa R, Lyons KE. Essential tremor: Differential diagnosis and current therapy. Am. J. Med. 2003;115:134–142. - PubMed
    1. Hubble JP, Busenbark KL, Pahwa R, Lyons K, Koller WC. Clinical expression of essential tremor: effects of gender and age. Mov. Disord. 1997;12:969–972. - PubMed
    1. Gorman WP, Cooper R, Pocock P, Campbell MJ. A comparison of primidone, propranolol, and placebo in essential tremor, using quantitative analysis. J. Neurol. Neurosurg. Psychiatr. 1986;49:64–68. - PMC - PubMed

Publication types

MeSH terms